The blood KL-6 level, which increases due to the excessive expression of pulmonary alveolar type II epithelial cells and an increase in alveolar vascular permeability, is a biomarker used for the diagnosis and evaluation of IP. This evidence concerns the gene MUC1 and incontinentia pigmenti.